Richard Chin's most recent trade in Cytek BioSciences Inc was a trade of 4,071 Common Stock done . Disclosure was reported to the exchange on Aug. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cytek BioSciences Inc | Richard Chin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2025 | 4,071 | 4,071 | - | - | Common Stock | |
| Cytek BioSciences Inc | Richard Chin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2025 | 4,071 | 69,218 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Richard Chin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 73,289 | 73,289 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Richard Chin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 39,062 | 39,062 | - | - | Director Stock Option (right to buy) |